In This Section

Program

Wednesday, June 24

Thursday, June 25

Friday, June 26

Saturday, June 27

Wednesday, June 24

REGISTRATION

1-7 p.m.

WELCOME AND OPENING Keynote

  • Opening Keynote Lecture
    Ron Levy, Stanford University, Stanford, California

Plenary Session 1: Antibodies through the eras

  • Gilles Salles, Memorial Sloan Kettering Cancer Center, New York, New York
Thursday, June 25

Plenary Session 2: Next Generation Clinical Assessment

  • Davide Rossi, Oncology Institute of Southern Switzerland, Bellinzona, Ticino, Switzerland
  • Genetics to inform therapy in lymphoma
    Margaret Shipp, Dana Farber Cancer Institute, Boston, Massachusetts
  • Integrating the microenvironment and omics into clinical workflows
    Christopher R. Flowers, The University of Texas MD Anderson Cancer Center, Houston, Texas

Plenary Session 3: The Lymphoma Microenvironment

  • Sandrine Roulland, Centre d’Immunologie de Marseille-Luminy, Marseille, France
  • Using the microenvironment to predict response to therapy
    Justin Kline, University of Chicago, Chicago, Illinois
  • Hodgkin lymphoma tumor microenvironment
    Christian Steidl, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

Plenary Session 4: Spatial Analysis of Lymphoma

  • Spatial transcriptomics of DLBCL
    Michael Green, The University of Texas MD Anderson Cancer Center, Houston, Texas
  • Transformation
    Erin Parry, Dana Farber Cancer Institute, Boston, Massachusetts
Friday, June 26

Plenary Session 5: New Targeted Therapeutic Strategies in Lymphoma

  • Chemotherapy-free strategies for large B-cell lymphoma
    Mark Roschewski, National Cancer Institute, Bethesda, Maryland

Plenary Session 6: Degraders in Lymphoma

  • Exploiting the E3 ligase FBXO21 as a novel therapeutic target and degrader in lymphoma
    Shannon Buckley, University of Utah, Salt Lake City, Utah
  • Francesco Bertoni, Oncology Institute of Southern Switzerland, Bellinzona, Ticino, Switzerland

Plenary Session 7: Rare Lymphomas

  • Jean Koff, Winship Cancer Institute of Emory University, Atlanta, Georgia
  • Navigating the landscape of peripheral T-cell lymphomas
    Teresa Palomero, Columbia University, New York, New York

Plenary Session 8: Advances in Cell Therapy

  • Armored CAR T cells
    Sarwish Rafiq, Winship Cancer Institute of Emory University, Atlanta, Georgia
  • Novel engineering strategies for CAR T cell therapy in lymphoma
    Laura Evgin, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
Saturday, June 27

Closing Keynote Lecture

  • Michel Nussenzweig, Rockefeller University, New York, New York

Plenary Session 9: Germinal Center Biology and Lymphomas

  • Cells of origin for lymphoma
    Dinis Calado, Francis Crick Institute, London, United Kingdom
  • Ari Melnick, Josep Carreras Institute, Badalona, Catalonia, Spain

Plenary Session 10: Epigenetics

  • Wendy Beguelin, New York University, New York, New York
  • Laura Pasqualucci, Columbia University, New York, New York